A detailed history of Oak Harvest Investment Services transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Oak Harvest Investment Services holds 2,779 shares of REGN stock, worth $2.1 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
2,779
Previous 2,212 25.63%
Holding current value
$2.1 Million
Previous $2.32 Million 25.69%
% of portfolio
0.42%
Previous 0.36%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$1024.09 - $1201.76 $580,659 - $681,397
567 Added 25.63%
2,779 $2.92 Million
Q2 2024

Oct 24, 2024

BUY
$883.2 - $1071.19 $384,192 - $465,967
435 Added 24.48%
2,212 $2.32 Million
Q2 2024

Jul 22, 2024

BUY
$883.2 - $1071.19 $119,232 - $144,610
135 Added 10.57%
1,412 $1.48 Million
Q1 2024

Oct 24, 2024

BUY
$902.69 - $993.35 $329,481 - $362,572
365 Added 25.85%
1,777 $1.71 Million
Q1 2024

Apr 19, 2024

BUY
$902.69 - $993.35 $59,577 - $65,561
66 Added 5.45%
1,277 $1.23 Million
Q4 2023

Jan 12, 2024

BUY
$775.18 - $881.7 $191,469 - $217,779
247 Added 25.62%
1,211 $1.06 Million
Q3 2023

Oct 25, 2023

SELL
$692.45 - $844.37 $8,309 - $10,132
-12 Reduced 1.23%
964 $793,000
Q2 2023

Jul 17, 2023

SELL
$700.03 - $830.35 $1.24 Million - $1.48 Million
-1,777 Reduced 64.55%
976 $701,000
Q1 2023

Apr 20, 2023

SELL
$680.49 - $826.97 $53,758 - $65,330
-79 Reduced 2.79%
2,753 $2.26 Million
Q4 2022

Jan 24, 2023

BUY
$705.89 - $766.39 $40,941 - $44,450
58 Added 2.09%
2,832 $0
Q3 2022

Oct 14, 2022

BUY
$573.97 - $724.32 $1.59 Million - $2.01 Million
2,774 New
2,774 $1.91 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Oak Harvest Investment Services Portfolio

Follow Oak Harvest Investment Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Harvest Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on Oak Harvest Investment Services with notifications on news.